Sanofi, 10% Owner at REGENERON PHARMACEUTICALS INC (REGN), bought 70,378 shares at $481.63 ($33.9M) on 2017-08-25, disclosed to the SEC on 2017-08-29.
Open-market purchase of $33.9M REGN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $479.19 | 3,684 | $1.8M | 5.2% |
| 2 | $479.93 | 28,586 | $13.7M | 40.5% |
| 3 | $480.75 | 21,360 | $10.3M | 30.3% |
| 4 | $481.63 | 1,302 | $627K | 1.9% |
| 5 | $482.87 | 4,485 | $2.2M | 6.4% |
| 6 | $485.28 | 5,723 |
| $2.8M |
| 8.2% |
| 7 | $485.99 | 2,681 | $1.3M | 3.8% |
| 8 | $487.01 | 2,557 | $1.2M | 3.7% |
| Total | $481.28 avg | 70,378 | $33.9M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |